TY - JOUR
T1 - Mechanism of inhibition of protein phosphatase 1 by DARPP-32
T2 - Studies with recombinant DARPP-32 and synthetic peptides
AU - Desdouits, F.
AU - Cheetham, J. J.
AU - Huang, H. B.
AU - Kwon, Y. G.
AU - Silva, E. F.D.E.
AU - Denefle, P.
AU - Ehrlich, M. E.
AU - Nairn, A. C.
AU - Greengard, P.
AU - Girault, J. A.
PY - 1995/1/17
Y1 - 1995/1/17
N2 - The mechanism of inhibition of protein phosphatase-1 catalytic subunit (PP-1c) by recombinant DARPP-32 and synthetic peptides was studied. DARPP-32 was expressed in Escherichia coli as a non-fusion protein using a pEt-3a plasmid, purified to homogeneity and shown to have physicochemical properties similar to those of the protein purified from bovine brain. Recombinant DARPP-32 phosphorylated on threonine-34 by cAMP-dependent protein kinase inhibited PP-1c with an IC50 (equivalent to) 0.5 nM, comparable to that obtained with bovine DARPP-32. Non-phosphorylated DARPP-32, and mutated forms in which threonine-34 was replaced by an alanine or a glutamic acid, inhibited PP-1c with an IC50 (equivalent to) 1 μM. Surface plasmon resonance analysis showed binding of PP-1c to nonphospho- and phospho-DARPP-32-(8-38) synthetic peptides with apparent Kd values of 1.2 and 0.3 μM, respectively, supporting the existence of an interaction between non-phosphorylated DARPP-32 and PP-1c that is increased by phosphorylation of DARPP-32 at threonine-34. These results suggest a model in which DARPP-32 interacts with PP-1c by at least two low affinity sites, the combination of which is responsible for the high affinity (nM) inhibition.
AB - The mechanism of inhibition of protein phosphatase-1 catalytic subunit (PP-1c) by recombinant DARPP-32 and synthetic peptides was studied. DARPP-32 was expressed in Escherichia coli as a non-fusion protein using a pEt-3a plasmid, purified to homogeneity and shown to have physicochemical properties similar to those of the protein purified from bovine brain. Recombinant DARPP-32 phosphorylated on threonine-34 by cAMP-dependent protein kinase inhibited PP-1c with an IC50 (equivalent to) 0.5 nM, comparable to that obtained with bovine DARPP-32. Non-phosphorylated DARPP-32, and mutated forms in which threonine-34 was replaced by an alanine or a glutamic acid, inhibited PP-1c with an IC50 (equivalent to) 1 μM. Surface plasmon resonance analysis showed binding of PP-1c to nonphospho- and phospho-DARPP-32-(8-38) synthetic peptides with apparent Kd values of 1.2 and 0.3 μM, respectively, supporting the existence of an interaction between non-phosphorylated DARPP-32 and PP-1c that is increased by phosphorylation of DARPP-32 at threonine-34. These results suggest a model in which DARPP-32 interacts with PP-1c by at least two low affinity sites, the combination of which is responsible for the high affinity (nM) inhibition.
UR - http://www.scopus.com/inward/record.url?scp=0028899611&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0028899611&partnerID=8YFLogxK
U2 - 10.1006/bbrc.1995.1092
DO - 10.1006/bbrc.1995.1092
M3 - Article
C2 - 7826384
AN - SCOPUS:0028899611
SN - 0006-291X
VL - 206
SP - 652
EP - 658
JO - Biochemical and Biophysical Research Communications
JF - Biochemical and Biophysical Research Communications
IS - 2
ER -